Keyur P. Patel
East Tennessee State University(US)The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)Thomas Jefferson University(US)National Medical Products Administration(CN)Thomas Jefferson University Hospital(US)Johnson City Medical Center(US)Online Technologies (United States)(US)Rothman Orthopaedics(US)Foundation for Human Potential(US)Ta Solutions (China)(CN)Rothman Institute(US)Drexel University(US)National Patient Safety Foundation(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Cancer Genomics and Diagnostics, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms(2022)3,654 cited
- → Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML(2020)633 cited
- → Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study(2018)563 cited
- → Ibrutinib and Venetoclax for First-Line Treatment of CLL(2019)495 cited
- → Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials(2015)425 cited
- → Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study(2016)391 cited